IB WCS 24
MENSTRUAL DISORDERS
Dr Ernest Ng
O&G
Sat 14-09-02
NORMAL PERIODS
Cycle length: 23-39 days (mean = 30 days)
Duration: 2-8 days (mean = 5 days)
Volume: <80 ml/ cycle
- Difficult to assess; woman can't measure blood loss, blood seen may be partly serum
- Ask subjective feeling: eg. How many pads/ day, soaked through, clots?
- If frequently > 80ml/ cycle
® anaemia
- No intermenstrual bleeding/pre- or post-menstrual bleeding
ABNORMAL PERIODS
Change in frequency
- Amenorrhoea: absence or abnormal stoppage of the menses (a symptom not a disease)
- Oligomenorrhoea: abnormally infrequent menstruation
- Polymenorrhoea: abnormally frequent menstruation
- Hypomenorrhoea: diminution of menstrual flow or duration
- Menorrhagia (> 10d)
- Hypomenorrhoea: diminution of menstrual flow or duration
- Menorrhagia
PRESENTING SYMPTOMS
- Intermenstrual bleeding
- Amenorrhoea / oligomenorrhoea
- Menorrhagia
- Hypomenorrhoea
INTERMENSTRUAL BLEEDING
DDX
Uterine
- Ovulation bleeding: due to drop in hormone level
- Endometrial polyp
- Fibroid polyp
Cervix
- Polyp
- Cervicitis
- CIN/CA (cervical intraepithelial neoplasm)
Vagina/vulva
- VIN/CA (vaginal intraepithelial neoplasm)
IX
P/E:
- Vaginal examination: lesions in vaginal and vulval region?
- Cervical smear: polyps, growths, subclinical change/ changes at histological level [only take if no obvious lesion seen]
- Biopsy of obvious growth: cervical smear not good enough (surface of growth may be dried out, therefore not true indicate of underlying histopathology)
- Hysteroscopy if persistent
- Look inside uterine cavity
- Any polyps?
MX
Depends on type and stage of disease
- Cervical polyp - avulsion, f'up for further bleeding
- CIN/CA:
- Colposcopy: microscope that magnifies view of cervix, abnormal staining, vascularisation?
- Excision: diathermy (take large area of abnormality out); laser; cryotherapy
- Radiotherapy
- Endometrial / fibroid polyp: hysteroscopic excision
AMENORRHOEA/ OLIGOMENORRHOEA
Hx
Need to determine sexual development
TB
Ab pain
PCOS: hyperandrogenisation (wt gain, hair growth, acne)
Eye sight (pituitary failure)
Milk expression (prolactin)
Hypothalamic-pituitary glands
- Pituitary failure
- Increased Prolactin
- Stress
- Wt loss/ Obesity
- Ix: FSH, LH, Prolactin ®
high FSH: causes ovarian failure (high input signal - FSH - causes ovarian overworking); need to check FSH:LH ratio (N = 1:1) (PCOS 1:3)
- Prolactin: if elevated, re-check (prolactin is a stress hormone - eg. During vaginal, cervical, breast examination)
Thyroid + Adrenal glands
Ix: T4
Uterus
- Imperforate hymen: hymen bulges forward (also in rectum); bulky uterus (collection of blood)
- Congenital absence
- Atresia of cervix/ vagina
- Acquired: eg. TB (endometrium destroyed)
Ix: P/E
Even if has lower genital tract pathology, till still undergo ovulation, woman well oestrogenised
Obstruction: menstrual flow cannot exit - therefore regular pain (every month
If repeated -> endometriosis
Note: in normal menstruation, there is retrograde menstrual flow into peritoneum (?)
Ovaries
- Ovarian failure
- PCOS: PolyCystic Ovarian Syndrome
[USS]
50% of ovarian failure are chromosome abnormalities (eg. Turner's syndrome: 45X)
Also chemotherapy/ radiation: eg. Leukaemia
No oestrogen produced at all - therefore body habitus remains child-like
Traditional stigmata not always present (as not all cells are 45X)
DIAG: Transvaginal scanning
PCOS
L = longitudinal section
R = transverse section
Dark spaces = follicles
CONCERNS
Depends on whether Pt is producing oestrogen or not (¯ oestrogen has assoc. health risks - similar to menopause) ® eg. Lose Ca++ from bone (osteoporosis)
Anovulation
[Ovulation induction]
Unopposed E2
- Increased endometrial ca: after a few years (unopposed oestrogen action has long-term stimulatory effect on endometrium -> hyperplastic) (If present for a few years, increase 7x chance; give progesterone Tx)
- PCOS
[Regular bleed]
Normal cycle: drop in oestrogen levels causes decreased proliferation of endometrium
Once progesterone decreases, endometrium is shed
This decreases a normal woman's risk for endometrial cancer
Low E2
- Osteoporosis: need HRT
- Ovarian failure
- Anorexia nervosa
[HRT]
MX OF ANOVULATION
FSH/ LH/ Prolactin
- Increased Prolactin
- Increased FSH
- Normal FSH/ LH
- Hyperprolactinaemia - Bromocriptine
- PCOS/ Hypothalamic - Wt reduction, Drugs, Surg (esp. PCOS)
- Ovarian failure - Donor eggs (ethics)
OVULATION INDUCTION
Weight reduction
Drugs
- Clomiphene citrate
- Gonadotrophin releasing hormone agonist--pulsatile manner via a pump
- Gonadotrophin injection
- Insulin sensitising agents (metformin)
Surgery: Ovarian drilling
MENORRHAGIA
Excessive bleeding (either volume or duration)
DDX
Focus on upper genital tract (more common)
General
- Bleeding disorders: clotting factor, platelet
Uterine
- Fibroid/ fibroid polyp
- Adenomyosis
- IUCD
- CA
- DUB
Cervix
Vagina
DUB
- Abnormal bleeding (usu. amount) from the uterus in the absence of organic disease of the genital tract
- Abnormal bleeding from the uterus unassociated with tumour, inflammation or pregnancy
- Diagnosis by exclusion
Mechanisms
Systemic
- Low platelet count
- Hypothalamic-pituitary causes
- Hyperprolactinaemia
- Thyroid/adrenal dysfunction
- Most of the cycles are ovulatory (therefore most causes are not systemic; they are local
Local
- Failure in vasoconstriction (increased PGE2/PGF2)
- Thrombotic plugs fails to form (prostacyclin)
- Excessive fibrinolysis (plaque formed but does not hold)
- Failure in vascular endothelial proliferation
- Delay in endometrial regeneration
Note: Stopping menstrual flow
- VC
- Thrombotic plaque
- Tissue regeneration/ repithelialisation on endometrial surface
Hx
- Presenting symptoms: meaning, duration, previous investigations/ treatment
- Symptoms of anaemia (b/c difficult to measure blood loss; determines Tx type and urgency)
- Other menstrual characteristics: pain during menstruation (fibroids, endometriosis - pain severe)
- Medical problems
- Current medication (drugs leading to clotting dysfunction)
P/E
- Signs of anaemia
- Any bleeding disorder: eg. Bruises
- Any thyroid enlargement
- Vaginal examination: local lesions
- Cervix
- Uterine size and regularity: irregularity suggests fibroids
Ix
Depends on suspicion
Eg. Won't perform invasive tests on young girl (b/c less fear of ca)
- Cervical smear
- Blood
- Complete blood counts
- Thyroid function
- Endometrial aspiration: histology
- US: upper genital tract
- Hysteroscopy/curettage: look at endometrial lining
DIAG: Endometrial aspiration
- Performed in office
- Insert inner shift - remove outer shift
- This creates -ve pressure (draws cancer cells more easily than normal endometrial cells; cannot withdraw polyps)
- Small knife cuts endometriosis, sucked out ® examine histologically (hyperplasia, malignancy?)
- Cannot Dx polyps (polyps can be visualised grossly)
DIAG: US examination - Fibroid
- Right: different echogenicity
DIAG: Transvaginal scanning - Fibroid polyp
DIAG: Hysteroscopy - Adenocarcinoma, Polyp
Telescope inserted into uterine cavity
Tx
- Exclusion of organic causes
- Explanation/counselling
- Observation
- Control of bleeding pattern
- Treating anaemia
Control of bleeding pattern
Immediate
- D&C: no long-term effects
- Premarin (IV)
- For women with excessive bleeding (may cause shock)
Short-term
- NSAID eg. Ponstan
- Anti-fibrinolytic agents eg. transamine
- Hormones eg. Progestogen, combined pills, danazol, GnRHa (prime endometrium, make lining thin)
- Progestogen releasing IUCD
Long-term
- Hysterectomy - abdominal, vaginal, laparoscopic approach
- Endometrial ablation-resection, laser, microwave
HYPOMENORRHOEA
Asherman Syndrome
Excessive uterine curettage -> uterine adhesion
Hypomenorrhoea, amenorrhoea, infertility, recurrent abortion
HSG / hysteroscopy (dangerous: uterus has adhesions, telescope may go through uterus; therefore performed in tertiary institute with speciality care)
Mx
Hysteroscopic lysis of adhesion (cannot perform 'blind' lysis)
IUCD-in-situ: After removing adhesions, put something in uterus to cover up raw areas (prevents further adhesions forming)
Hormonal therapy for 3 mo (stimulate endometrium to reepithelialise the area to prevent further adhesions forming)